CHF5259
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CHF5259, covering 2016-12-29 to 2020-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD [Phase 2]